sibeprenlimab (VIS649) / Otsuka  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sibeprenlimab (VIS649) / Otsuka
NCT03719443: First in Human Study to Assess Safety of VIS649 in Healthy Subjects

Completed
1
41
US
VIS649, Placebo
Visterra, Inc.
Immunoglobulin A Nephropathy, IgAN - IgA Nephropathy, IgA Nephropathy
08/19
08/19

Download Options